Soligenix (SNGX.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec19

Soligenix Announces Positive Results for SGX945 in Treatment of Behcet's Disease IIa Phase Clinical Trial

10:28

Analyst Reiterates Buy Rating and Price Target for Soligenix

07:32

Nov8

Soligenix released FY2025 9 Months Earnings on November 7, 2025 (EST), actual revenue USD 0, actual EPS USD -2.47

04:00

Soligenix released FY2025 Q3 earnings on November 7 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5845 (forecast USD -0.63)

04:00

Nov4

Soligenix Inc Expected to Report Flat Quarterly Revenue

14:11

Sep30

Soligenix Expands European Medical Advisory Board to Advance HyBryte Clinical Trials

11:30

Schedules & Filings

Schedules

Filings

Nov7

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -2.531 M, EPS -0.5845

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.702 M, EPS -0.8241

May9

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -3.237 M, EPS -1.0613

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More